Antitumor Effect of Periplocin in TRAIL‐Resistant gastric cancer cells via upregulation of death receptor through activating ERK1/2‐EGR1 pathway
- 9 February 2019
- journal article
- research article
- Published by Wiley in Molecular Carcinogenesis
- Vol. 58 (6) , 1033-1045
Abstract
Tumor necrosis factor‐related apoptosis‐inducing ligand (TRAIL), a member of the tumor necrosis factor family, induces apoptosis in a variety of cancer cells. However, gastric cancer (GC) cells are insensitive to TRAIL usually. In the previous study, we showed that Periplocin could induce apoptosis in GC cells via the activation of ERK1/2‐EGR1 pathway. In the present study, we have shown that the combination of Periplocin and TRAIL had a greater inhibitory effect on gastric cancer cell viability in vitro and in vivo than Periplocin or TRAIL alone. Through upregulating the expression of DR4 and DR5 at transcriptional and protein levels, Periplocin enhanced the sensitivity of gastric cancer cells to TRAIL. Furthermore, enhanced activity of ERK1/2‐EGR1 pathway was responsible for upregulating of DR4 and DR5 uponPeriplocin treatment, subsequently reducing the expression of Mcl‐1 and Bcl2 and activating Bid and caspase‐3/8. Collectively, these data implied that Periplocin might act as a sensitizer of TRAIL and could be a potential strategy for the treatment of GC.This article is protected by copyright. All rights reservedKeywords
Funding Information
- National Natural Science Foundation of China (81673642, 81502032, 81772550)
- Beijing Nova Program (Z181100006218061)
This publication has 35 references indexed in Scilit:
- Dual Inactivation of Akt and ERK by TIC10 Signals Foxo3a Nuclear Translocation, TRAIL Gene Induction, and Potent Antitumor EffectsScience Translational Medicine, 2013
- Resistance to TRAIL Is Mediated by DARPP-32 in Gastric CancerClinical Cancer Research, 2012
- Off-Target Lapatinib Activity Sensitizes Colon Cancer Cells Through TRAIL Death Receptor Up-RegulationScience Translational Medicine, 2011
- BCR–ABL-mediated upregulation of PRAME is responsible for knocking down TRAIL in CML patientsOncogene, 2010
- DR5‐mediated DISC controls caspase‐8 cleavage and initiation of apoptosis in human glioblastomasJournal of Cellular and Molecular Medicine, 2010
- Playing the DISC: Turning on TRAIL death receptor-mediated apoptosis in cancerBiochimica et Biophysica Acta (BBA) - Reviews on Cancer, 2010
- Zerumbone Enhances TRAIL-Induced Apoptosis through the Induction of Death Receptors in Human Colon Cancer Cells: Evidence for an Essential Role of Reactive Oxygen SpeciesCancer Research, 2009
- XIAP discriminates between type I and type II FAS-induced apoptosisNature, 2009
- c-Jun NH2-Terminal Kinase-Mediated Up-regulation of Death Receptor 5 Contributes to Induction of Apoptosis by the Novel Synthetic Triterpenoid Methyl-2-Cyano-3,12-Dioxooleana-1, 9-Dien-28-Oate in Human Lung Cancer CellsCancer Research, 2004
- Identification and characterization of a new member of the TNF family that induces apoptosisImmunity, 1995